BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37083126)

  • 21. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
    Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
    Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
    Chen FM; Du M; Qi X; Bian L; Wu D; Zhang SL; Wang J; Zhou Y; Zhu X
    J Magn Reson Imaging; 2023 Jun; 57(6):1893-1905. PubMed ID: 36259347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.
    Wan P; Zhang J; Long X; Li Q; Xu N; Zhang M; Chen X; Han L; Xia Q
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):553-61. PubMed ID: 24589829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
    Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
    Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cox Nomogram for Assessing Recurrence Free Survival in Hepatocellular Carcinoma Following Surgical Resection Using Dynamic Contrast-Enhanced MRI Radiomics.
    Cao X; Yang H; Luo X; Zou L; Zhang Q; Li Q; Zhang J; Li X; Shi Y; Jin C
    J Magn Reson Imaging; 2023 Dec; 58(6):1930-1941. PubMed ID: 37177868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
    Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
    BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.
    Wang JC; Hou JY; Chen JC; Xiang CL; Mao XH; Yang B; Li Q; Liu QB; Chen J; Ye ZW; Peng W; Sun XQ; Chen MS; Zhou QF; Zhang YJ
    Eur J Cancer; 2021 Sep; 155():85-96. PubMed ID: 34371445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
    Kim AY; Sinn DH; Jeong WK; Kim YK; Kang TW; Ha SY; Park CK; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim MJ; Sohn I; Jung SH; Paik SW; Lee WJ
    J Hepatol; 2018 Jun; 68(6):1144-1152. PubMed ID: 29410377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma.
    Li J; Zhou J; Yang PH; Xia Y; Shi YH; Wu D; Lv G; Zheng W; Wang K; Wan XY; Lau WY; Wu MC; Fan J; Shen F
    Eur J Cancer; 2016 Jul; 62():86-95. PubMed ID: 27232330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis.
    Xu L; Dai F; Wang P; Li L; Zhang M; Xu M
    BMC Surg; 2022 Sep; 22(1):339. PubMed ID: 36100893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
    Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
    Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.